COVID-19 Clinical Research Studies

Multimodal Single-Cell Omics Analysis of COVID-19 Sex Differences in Human Immune Systems

The paper examines sex differences in COVID-19 outcomes and immune responses using single-cell RNA-sequencing and clinical data, finding higher risk for males and potential mechanisms for sex-specific treatments.

Transcriptional differences for COVID-19 Disease Map genes between males and females indicate a different basal immunophenotype relevant to the disease

A repurposed, blood gene signature is associated with poor outcomes in SARS-CoV-2

The paper identifies a blood gene signature predictive of poor outcomes in SARS-CoV-2 infection by analyzing its cellular sources in single-cell data.

Genetically proxied inhibition of interleukin-6 signaling: opposing associations with susceptibility to COVID-19 and pneumonia

This study uses Mendelian randomization to show that genetically proxied IL-6 signaling inhibition reduces COVID-19 risk but increases pneumonia risk.

Clinical and molecular characterization of COVID-19 hospitalized patients

The paper reports Whole Exome Sequencing analysis of 35 hospitalized COVID-19 patients, identifying pathogenic mutations linked to virus infection susceptibility and disease progression.

Large-scale single-cell analysis reveals critical immune characteristics of COVID-19 patients

This study uses single-cell RNA sequencing to analyze immune responses in COVID-19 patients, identifying key immune cell changes and molecular pathways linked to disease severity.

Potential impact on coagulopathy of gene variants of coagulation related proteins that interact with SARS-CoV-2

The paper examines how genetic variants of coagulation-related proteins interacting with SARS-CoV-2 may influence COVID-19 severity, particularly in minority populations.

Single-cell analysis of severe COVID-19 patients reveals a monocyte-driven inflammatory storm attenuated by Tocilizumab

The paper uses single-cell analysis to show that Tocilizumab reduces monocyte-driven inflammation in severe COVID-19 but does not fully suppress immune responses.

Heparin as an Anti-Inflammatory Agent

This study investigates heparin's ability to inhibit IFN-gamma and IL-6 signaling pathways in COVID-19 to prevent cytokine release syndrome.

Unravelling the debate on heme effects in COVID-19 infections

The paper investigates the potential link between heme levels and COVID-19 pathogenesis by analyzing protein interactions and common pathways.

APOE E4 GENOTYPE PREDICTS SEVERE COVID-19 IN THE UK BIOBANK COMMUNITY COHORT

The paper investigates the association between ApoE e4 genotype and severe COVID-19 in the UK Biobank community cohort, finding a link with increased risk of severe outcomes.

Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells

The paper examines sex differences in ACE2 and TMPRSS2 expression in prostate and lung epithelial cells, finding higher ACE2 expression in male lung type II pneumocytes and co-expression in prostate club cells.

Clonal chromosomal mosaicism and loss of chromosome Y in men are risk factors for SARS-CoV-2 vulnerability in the elderly

The paper identifies clonal chromosomal mosaicism and loss of chromosome Y as risk factors for severe SARS-CoV-2 outcomes in elderly males.

Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection

In healthy human liver scRNA-seq, ACE2 is detected in 59.7% of cholangiocytes but 2.6% of hepatocytes, so 2019-nCoV may target bile duct cells rather than hepatocytes.